Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Avery

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
BMC Infectious Diseases|January 10, 2024
Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United StatesKelly K O'Brien, Kristine M Erlandson, Darren A Brown, et al.
The Science of the Total Environment|September 11, 2019
Water safety plan enhancements with improved drinking water quality detection techniquesMaria J Gunnarsdottir, Sigurdur M Gardarsson, Maria J Figueras, et al.
BMJ Global Health|March 2, 2023
Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative studyKelly K O'Brien, Darren A Brown, Kiera McDuff, et al.
BMJ Open|March 8, 2022
Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID - protocol for a mixed-methods studyKelly K O'Brien, Darren A Brown, Colm Bergin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 10, 2025
Community Engagement in Long Covid Research: Process, Evaluation and Recommendations From the Long COVID and Episodic Disability StudyMargaret E O'Hara, Kiera McDuff, Hannah Wei, et al.
Plos One|February 27, 2025
Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative studyKelly K O'Brien, Darren A Brown, Kiera McDuff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical TrialAbdulazeez Salawu, Ben X Wang, Ming Han, et al.
Clinical Colorectal Cancer|July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic CancerAlberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
BMC Infectious Diseases|January 10, 2024
Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United StatesKelly K O'Brien, Kristine M Erlandson, Darren A Brown, et al.
The Science of the Total Environment|September 11, 2019
Water safety plan enhancements with improved drinking water quality detection techniquesMaria J Gunnarsdottir, Sigurdur M Gardarsson, Maria J Figueras, et al.
BMJ Global Health|March 2, 2023
Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative studyKelly K O'Brien, Darren A Brown, Kiera McDuff, et al.
BMJ Open|March 8, 2022
Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID - protocol for a mixed-methods studyKelly K O'Brien, Darren A Brown, Colm Bergin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 10, 2025
Community Engagement in Long Covid Research: Process, Evaluation and Recommendations From the Long COVID and Episodic Disability StudyMargaret E O'Hara, Kiera McDuff, Hannah Wei, et al.
Plos One|February 27, 2025
Episodic disability framework in the context of Long COVID: Findings from a community-engaged international qualitative studyKelly K O'Brien, Darren A Brown, Kiera McDuff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical TrialAbdulazeez Salawu, Ben X Wang, Ming Han, et al.
Clinical Colorectal Cancer|July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic CancerAlberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Pageof 15